Jonathan Cullis

1.6k total citations
28 papers, 970 citations indexed

About

Jonathan Cullis is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Jonathan Cullis has authored 28 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 10 papers in Genetics and 6 papers in Immunology. Recurrent topics in Jonathan Cullis's work include Chronic Myeloid Leukemia Treatments (9 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Acute Myeloid Leukemia Research (5 papers). Jonathan Cullis is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Acute Myeloid Leukemia Research (5 papers). Jonathan Cullis collaborates with scholars based in United Kingdom. Jonathan Cullis's co-authors include Emmanuel Tsochatzis, Wayne Thomas, Edward J. Fitzsimons, William J. Griffiths, A. John Barrett, J M Goldman, John M. Dudley, Nay Win, Jill Hows and Anthony P. Schwarer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and BMJ.

In The Last Decade

Jonathan Cullis

26 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Cullis United Kingdom 14 746 359 137 135 134 28 970
Renu Saxena India 21 967 1.3× 417 1.2× 68 0.5× 100 0.7× 133 1.0× 123 1.3k
Guillermo J. Ruiz‐Delgado Mexico 17 616 0.8× 203 0.6× 155 1.1× 167 1.2× 180 1.3× 130 953
F. Hernández‐Navarro Spain 21 991 1.3× 441 1.2× 195 1.4× 71 0.5× 80 0.6× 58 1.4k
Jerome Teitel Canada 23 1.2k 1.6× 324 0.9× 67 0.5× 96 0.7× 146 1.1× 81 1.6k
Antonio Torres Spain 18 662 0.9× 319 0.9× 147 1.1× 239 1.8× 226 1.7× 44 1.2k
Y Beguin Belgium 19 698 0.9× 459 1.3× 111 0.8× 42 0.3× 117 0.9× 39 1.1k
Michael Steinbuch United States 14 613 0.8× 212 0.6× 288 2.1× 218 1.6× 187 1.4× 24 1.3k
Martin Mohren Germany 17 321 0.4× 170 0.5× 188 1.4× 187 1.4× 98 0.7× 37 936
Wim Terpstra Netherlands 18 542 0.7× 183 0.5× 276 2.0× 108 0.8× 317 2.4× 36 1.0k
Ignacio Lorenzo Spain 17 685 0.9× 226 0.6× 239 1.7× 97 0.7× 183 1.4× 34 946

Countries citing papers authored by Jonathan Cullis

Since Specialization
Citations

This map shows the geographic impact of Jonathan Cullis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Cullis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Cullis more than expected).

Fields of papers citing papers by Jonathan Cullis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Cullis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Cullis. The network helps show where Jonathan Cullis may publish in the future.

Co-authorship network of co-authors of Jonathan Cullis

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Cullis. A scholar is included among the top collaborators of Jonathan Cullis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Cullis. Jonathan Cullis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowers, Margaret, A. J. CHARLTON, Jonathan Cullis, et al.. (2024). Selinexor in combination with dexamethasone with or without bortezomib in heavily pretreated multiple myeloma: A case series. SHILAP Revista de lepidopterología. 5(5). 987–991.
2.
Cullis, Jonathan, et al.. (2015). Interpreting raised serum ferritin levels. BMJ. 351. h3692–h3692. 62 indexed citations
3.
Cullis, Jonathan. (2013). Anaemia of chronic disease. Clinical Medicine. 13(2). 193–196. 43 indexed citations
4.
Cullis, Jonathan. (2011). Diagnosis and management of anaemia of chronic disease: current status. British Journal of Haematology. 154(3). 289–300. 91 indexed citations
5.
Matthey, Francis, Anne Parker, Simon Rule, et al.. (2010). Facilities for the treatment of adults with haematological malignancies – 'Levels of Care': BCSH Haemato-Oncology Task Force 2009. Hematology. 15(2). 63–69. 9 indexed citations
6.
Beer, Philip, Amy V. Jones, Anthony J. Bench, et al.. (2009). Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones. British Journal of Haematology. 144(6). 904–908. 57 indexed citations
7.
Cullis, Jonathan & Rebecca Hyde. (2008). Acute epiglottitis in immunocompromised patients-a report of two cases. Clinical & Laboratory Haematology. 13(4). 379–382. 2 indexed citations
8.
Mathews, Christopher, et al.. (2007). Cost‐effectiveness of rituximab in refractory cold agglutinin disease. International Journal of Laboratory Hematology. 30(4). 331–333. 2 indexed citations
9.
Roberts, Emily, et al.. (2006). Blindness due to angioid streaks in congenital dyserythropoietic anaemia type I. British Journal of Haematology. 133(5). 456–456. 5 indexed citations
10.
Milligan, D, David Grimwade, Jonathan Cullis, et al.. (2006). Guidelines on the management of acute myeloid leukaemia in adults. British Journal of Haematology. 135(4). 450–474. 102 indexed citations
11.
Treleaven, J, et al.. (2005). Obtaining consent for chemotherapy. British Journal of Haematology. 132(5). 552–559. 5 indexed citations
12.
Ranaboldo, C. J., et al.. (2003). An audit of post-splenectomy prophylaxis – are we following the guidelines?. Annals of The Royal College of Surgeons of England. 85(4). 252–255. 40 indexed citations
13.
Ross, Fiona, et al.. (1999). Patients With Essential Thrombocythemia Do Not Express BCR-ABL Transcripts. Blood. 93(7). 2420–2421. 5 indexed citations
14.
Parker, Jane E., Antonio Pagliuca, Aleksandar Mijović, et al.. (1997). Fludarabine, cytarabine, G‐CSF and idarubicin (FLAG‐IDA) for the treatment of poor‐risk myelodysplastic syndromes and acute myeloid leukaemia. British Journal of Haematology. 99(4). 939–944. 122 indexed citations
15.
16.
Cullis, Jonathan, Richard Szydlo, Nicholas C.P. Cross, et al.. (1993). Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion.. PubMed. 11 Suppl 1. 107–11. 8 indexed citations
17.
Barrett, J. Carl, António Guimarães, Jonathan Cullis, & John M. Goldman. (1993). Immunological characterization of the tumor‐specificbcr/abljunction of philadelphia chromosome positive chronic myeloid leukemia. Stem Cells. 11(S3). 104–108. 10 indexed citations
18.
Marks, David I., Timothy P. Hughes, Richard Szydlo, et al.. (1992). HLA‐identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome. British Journal of Haematology. 81(3). 383–390. 37 indexed citations
19.
Cullis, Jonathan, Anthony P. Schwarer, Timothy P. Hughes, et al.. (1992). Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T‐depleted donor marrow: feasibility of using busulphan alone for re‐conditioning. British Journal of Haematology. 80(1). 33–39. 31 indexed citations
20.
Cullis, Jonathan, D I Marks, Anthony P. Schwarer, et al.. (1992). Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases. British Journal of Haematology. 81(3). 378–382. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renu Saxena Breakdown of academic impact, for papers by Guillermo J. Ruiz‐Delgado Breakdown of academic impact, for papers by F. Hernández‐Navarro Breakdown of academic impact, for papers by Jerome Teitel Breakdown of academic impact, for papers by Antonio Torres Breakdown of academic impact, for papers by Y Beguin Breakdown of academic impact, for papers by Michael Steinbuch Breakdown of academic impact, for papers by Martin Mohren Breakdown of academic impact, for papers by Wim Terpstra Breakdown of academic impact, for papers by Ignacio Lorenzo
Rankless by CCL
2026